Biotechnology major Biocon on Thursday reported over two-fold jump in consolidated net profit to ₹ 217.2 crore for the third quarter ended December 2018, mainly on account of strong performance of its biologics business.
The company had posted a net profit of ₹ 91.9 crore for the corresponding period of the previous fiscal, Biocon said in a filing to the BSE.
Its consolidated revenue from operations stood at ₹ 1,540.8 crore for the quarter against ₹1,057.9 crore, it added.
Shares of Biocon Ltd closed at ₹ 670.55 per scrip on the BSE, up 0.04 per cent from the previous close.